BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

May 22, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-05-21

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-21	Common Stock	S	1545	$56.192	Disposed	47195	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	180257	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 trading plan executed on August 9, 2013.

F2: The price in column 4 is a weighted average price. The price actually received ranged from $55.72 to $56.99. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: The reporting person and his spouse act as trustees for the Bienaime Family Trust.